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Growth cone formationIn axotomised regenerating axons, the ﬁrst step toward successful regeneration is the formation of a growth
cone. This requires a variety of dynamic morphological and biochemical changes in the axon, including the
appearance of many new cytoskeletal, cell surface and signalling molecules. These changes suggest the
activation of coordinated complex cellular processes. A recent development has been the demonstration that
the regenerative ability of some axons depends on their capacity to locally synthesise new proteins and
degrade others at the injury site autonomously from the cell body. There are also events involving the
degradation of cytoskeletal and other molecules, and activation of signalling pathways, with axotomy-
induced calcium changes probably being an initiating event. A future challenge will be to understand how
this complex network of processes interacts in order to ﬁnd therapeutic ways of promoting the regeneration
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Injury to the nerve results in disconnection of the cell body from
the distal target. In such injuries, axons are broken into at least two
major fragments. The distal portion becomes physically separated
from the cell body and undergoes Wallerian degeneration, culminating
in its degradation. The proximal portion, which is still attached to the
cell body, usually initiates a regenerative phase in order to re-grow
towards its targets. This phenomenon of axon regeneration is much
more successful in the peripheral nervous system (PNS), as compared
to the central nervous system (CNS). In the former, damaged axons are
generally capable of re-growing a long distance to result in functional
recovery. On the contrary, neurons from the CNS are notoriously poor atRepair, E.D. Adrian Building,
: +44 1223 331174.
 license. regenerating axons after an injury. Regeneration requires the re-
creation of the axon growth cone, a specialised motile structure that
contains manymolecules and signalling pathways that are not found in
the mid part of mature axons. Much effort has been put into
understanding the processes and mechanisms that underlie axon
regeneration particularly in the PNS, with the hope of translating some
useful knowledge into improving regeneration of the CNS. In this
review, we aim to provide a summary of the current understanding of
the roles of one of the mechanisms, i.e. local axonal protein synthesis
and protein degradation in mediating axon regeneration.Axon dynamics after injury
As a result of transection, the plasma membrane of the cut axon
tip becomes damaged, and the axoplasm is exposed to the
extracellular environment. This causes leakage of intracellular
contents or the inﬂux of materials in the opposite direction, either
Fig.1. (A) Inside a healthy axon, a variety of protein synthesis and degradationmachinery is present. (B) As a result of transection, the axon is divided into two parts. The distal portion
undergoesWallerian degeneration and will subsequently be degraded. In the proximal portion, calcium enters the axon due to the disruption to the plasma membrane, as well as via
voltage-gated calcium channels. Cytoskeletal structures such as microtubules and neuroﬁlament undergo depolymerisation and degradation. Neurotrophins from extracellular
sources may also help the localisation of mRNAs. (C) Later on, a terminal swelling appears at the tip of the proximal stump, as regeneration ensues. Microtubules and neuroﬁlaments
undergo re-polymerisation. Protein synthesis and protein degradation occur simultaneously within the axon. Protein synthesis takes place via a mechanism dependent on mTOR,
ERK 1/2 and PKA. Examples of proteins synthesised locally after an injury include importin b1, vimentin, ribosomal protein L4 etc. Protein degradation may occur via calpain-
dependent proteolysis (e.g. vimentin, spectrin) or ubiquitin–proteasome system, while the role of autophagy remains to be elucidated.
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successful regeneration, the axon ﬁrst needs to re-seal the damaged
membrane of the proximal tip to preserve the intra-axonal milieu
(Eddleman et al., 2000; Spira et al., 1993, 1996). Then, the neuron
must be able to convert the axon into a new growth cone. This is
achieved by a highly dynamic process involving the remodelling of
the intracellular cytoskeleton inside the axon, as well as the
modiﬁcation of the membrane and membrane-associated mole-
cules, to transform it from a cylindrical tube into an expansive,
dynamic, and motile structure that can grow through the
surrounding environment and respond to growth and guidance
cues (Sahly et al., 2006).
Events leading up to the formation of a growth cone post-axotomy
have been studied in greatest depth in cultured Aplysia neurons. First,the proximal stump degenerates a small extent as the membrane
seals, associated with the activation of calpains and degradation of
cytoskeletal elements. This is followed by the appearance of an area of
swelling or enlargement near the axon terminal within 5 min (Spira
et al., 2003; Verma et al., 2005). In the invertebrate Aplysia, the axon
then becomes broadly divided into 3 zones—namely proximal,
transition and distal zones—correlating with the distance from the
cell body. This happens as a result of a reorganisation of the cyto-
skeleton via the breakdown and re-polymerisation of microtubules,
neuroﬁlaments and actin ﬁlaments (Spira et al., 2003). In the proximal
zone, the cytoskeletal structure remains intact; whereas in the distal
zone, the breakdown products of microtubules and neuroﬁlaments
form electron-dense aggregates (Sahly et al., 2006; Spira et al., 2003).
The transition zone undergoes an initial accumulation of vesicles due
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organising centre for the nascent growth cone (Spira et al., 2003).
Then, actin ﬁlaments polymerise along the periphery of the transition
zone, forming the expanding lamellipodium of the growth cone (Sahly
et al., 2006; Spira et al., 2003). Further polymerisation of cytoskeletal
elements is believed to support the re-structuring of the growth cone
and the regeneration of the axon.
The events following axotomy of mammalian neurons in vitro are
probably similar, but have not been described in the same degree of
detail as for Aplysia. There is an initial axonal withdrawal from the site
of axotomy, usually followed in sensory neurons by the regeneration
of a new growth cone (Chierzi et al., 2005; Verma et al., 2005). When
comparing neurons cultured from rat dorsal root ganglion (DRG)
neurons and retinal ganglion cells (RGCs), it was found that the ter-
minal swelling in DRG axons are mostly transformed into a new
growth cone, but those from RGCs tend not to do so (Verma et al.,
2005). This is consistent with the widely-held idea that CNS (i.e. RGC)
neurons have a lower regenerative capacity compared to PNS (i.e.
DRG) neurons. Besides, there is also a progressive developmental
decline of regenerative ability, reﬂecting the effect of ageing on re-
generation (Chierzi et al., 2005; Verma et al., 2005).
The observation that transected axons undergo a series of pro-
cesses involving retraction, terminal enlargement formation, growth
cone re-formation and axon extension, indicates that a dynamic
protein turnover event must be occurring. New proteins are being
synthesised while old ones are degraded. This interplay between
protein synthesis and degradation must be tightly regulated so as to
orchestrate the transformation of the axonal terminal stump into a
well-formed growth cone in an orderly fashion.
The role of protein synthesis in axon regeneration
The identiﬁcation and localisation of protein synthesis machinery
in axons
Recent work from our laboratory attempted to ﬁnd out the role, if
any, of local axonal protein synthesis during axon regeneration after
axotomy. Using DRG neuron cultures, we severed the axons extending
from the explants with a glass electrode and observedwith time-lapse
microscopy (Verma et al., 2005). We saw that many neurons success-
fully re-form new growth cones within just 20 min post-axotomy, and
when analysed after 4 h, a large percentage of DRG neurons (∼80% in
embryos, ∼70% in adults) had successfully regenerated a new growth
cone (Verma et al., 2005). Such a fast response argues for a local
regulation of regenerative events post-axotomy, because most
molecules are not transported fast enough for newly synthesised
material to have arrived from the cell body. Indeed, virtually identical
results were obtained when the growth cone regeneration assay was
carried out on axons that had been disconnected from their cell
bodies, thus ruling out any overriding control from there. Importantly,
the application of protein synthesis inhibitors, cycloheximide and
anisomycin, signiﬁcantly impairs the growth cone regenerative ability
(Verma et al., 2005). This implies that the ability of axons to undertake
local protein synthesis could underlie their capability to regenerate
post-axotomy, at least in the early stages (within 4 h). And to achieve
that, it means that machinery that carries out protein synthesis must
be in place beforehand, or must be rapidly localised to the injured site.
Evidence of the axonal localisation of protein synthesis machinery
came from several studies. Early reports demonstrated the localisation
of mRNAs, tRNAs, rRNAs and elongation factors to the squid giant axon
and the Mauthner axon of the goldﬁsh. Later, regenerating adult rat
sensory axons were shown to contain several ribosomal proteins (P0,
L4, L29, L17 and RPP) in addition to translation initiation factors
(eIF2α, eIF4e and eIF5) (reviewed by Piper and Holt, 2004; Verma et
al., 2005; Zheng et al., 2001). Although initial attempts to detect
ribosomes in mature axons using conventional electron microscopyfailed, with the development of high-resolution electron microscopy
techniques, the presence of ribosomeswas observed in the axoplasmic
compartment of invertebrate and mammalian vertebrate axons. The
ribosomes appeared to be organised into plaque-like structures on the
outer boundary of the axoplasm and colocalised with a cytoskeletal
matrix composed of F-actin (Koenig and Martin, 1996; Koenig et al.,
2000; Kun et al., 2007; Pannese and Ledda,1991; Sotelo et al., 1999). In
addition, immunostaining with the Y10B antibody against 28 s rRNA
detected the presence of rRNA in the axons (Lerner et al., 1981; Zheng
et al., 2001). Recently, convincing evidence of the localisation of
ribosomes to adult axons comes from the work of Court et al. (2008).
In this study, endogenous ribosomes (presumably transported from
the cell body) were detected in the mouse sciatic nerve. Surprisingly,
after nerve damage Schwann cells appeared to transfer their own
ribosomes into the axon.
To date several hundred mRNAs have been identiﬁed and localised
to axons (Fig. 1A). Initially, the identiﬁcation was carried out in inver-
tebrate axons (Chun et al., 1995,1997; Gioio et al., 2004; Giuditta et al.,
1991; reviewed in Alvarez et al., 2000). Currently, approximately 40
different mRNAs have been detected, including mRNAs for ribosomal
proteins, cytoskeletal proteins, motor proteins, translation factors,
nuclear-encodedmitochondrial proteins andmany others (Gioio et al.,
2004). In mammalian axons, a large number of mRNAs have been
identiﬁed by the combined use of molecular biology, metabolic
labelling and new proteomic methodologies (Eng et al., 1999; Willis
et al., 2005, 2007). Preliminary studies focused on developing axons
(Bassell et al., 1998; Cox et al., 2008; Eng et al., 1999; Olink-Coux and
Hollenbeck, 1996; Wu et al., 2005) and later on regenerating adult
sensory and motor axons in vitro and in vivo (Hanz et al., 2003; Koenig
et al., 2000; Perlson et al., 2005; Verma et al., 2005; Willis et al., 2005,
2007; Yudin et al., 2008; Zheng et al., 2001). By RT-PCR the mRNAs of
cytoskeletal proteins (such as β-actin, β-tubulin, vimentin, NF-L), heat
shock proteins, resident endoplasmic reticulum (ER) proteins and
othermRNAs encoding proteins related to neurodegenerative diseases
andmetabolismwere detected (Willis et al., 2005; Zheng et al., 2001).
To increase the number of mRNAs identiﬁed in axons, Willis et al.
(2007) extracted mRNAs from pure axonal preparations and reverse
transcribed these into cDNAs that were subsequently ampliﬁed. These
were then hybridised onto cDNA arrays that contain about 4000 rat
cDNAs. Their study revealed that over 200 mRNAs were present in the
adult sensory axons of injury-conditioned DRG. We (L. Gumy and J.W.
Fawcett; unpublished data) have recently characterised mRNAs from
uninjured adult sensory axons and functionally classiﬁed the mRNAs
by gene ontology. Remarkably, the most abundant functional groups
appeared to be the ribosomal/translational machinery and the
mitochondrial/oxidative phosphorylation ones. About 58 mRNAs for
ribosomal proteins were present in the array out of 80 rat ribosomal
proteins that have been described to date (Wool et al., 1995). In-
terestingly, several components of the ubiquitin–proteasome system
appeared clustered together, including ubiquitin c. Curiously, some
nuclear proteins such as histones and transcription factors were also
present and several signalling proteins and cytoskeletal components
were detected, corroborating previous reports. Recently, Taylor et al.
(2009) provided evidence that CNS axons also contain many localised
mRNAs of diverse function. Interestingly, the authors found that the
composition of axonal mRNAs changed after axonal injury and during
regeneration, where an increase in transcripts related to axonal
outgrowth, targeting and synapse formation was observed (for more
details on injury-induced RNA transport see review by Yoo et al.,
2010). Many of the mRNAs found in naive and injured CNS axons
match those reported in PNS axons. For example, CNS axons also
appear to contain a high number of transcripts related to ribosomal
proteins as reported in previous studies. Similarly, in invertebrate
axons it also appears that some of the most abundant and highly
representedmRNAs encode for ribosomal proteins (Gioio et al., 2004).
Perhaps future work will highlight whether mRNAs encoding
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proteins can exert functions speciﬁcally adapted to the physiology of
the axon and growth cone.
The possible mechanisms for axonal mRNA sorting and transport
have been extensively reviewed (Bassell and Kelic, 2004; Du et al.,
2007; Kindler et al., 2005; Sossin and DesGroseillers, 2006; Sotelo-
Silveira et al., 2006; Wang et al., 2007). Brieﬂy, active sorting and
transport involves the identiﬁcation of speciﬁc sequences and
structures within the mRNA (e.g. “zipcode” in the 3′ untranslated
region (UTR) of β-actin) by RNA-binding factors. The interaction be-
tween the mRNA and the RNA-binding factors (e.g. Staufen, kinesins)
results in the formation of ribonucleotide complexes that travel along
axonal microtubules. The speciﬁc targeting of the mRNA (e.g.
dendrites or axons in CNS neurons) appears to depend on the tar-
geting elements within the mRNA, the RNA-binding factors present
and the activity of the neuron. Below, we examine recent ﬁndings on
the localisation of mRNAs by extracellular cues during regeneration.
Willis et al. (2005) showed that the bath application of neuro-
trophins increased the transport of β-actin mRNA to the growth cone.
Subsequently, it was shown that several neurotrophins (NGF, BDNF,
NT-3) as well as inhibitory molecules (MAG, Sema3A) modiﬁed the
levels of particular mRNAs in the axons (Willis et al., 2007; Fig. 1B).
Very elegantly it was reported on how these ligands speciﬁcally
increased or decreased the localisation of 50 mRNAs that belong to a
wide range of protein families. Furthermore, it was found that the
speciﬁc ligand-induced localisation of the mRNAs in the axon was
independent of new transcription and correlated with mRNA changes
in the cell body. Consequently, it was established that extracellular
stimuli could target and redistribute pre-existing mRNAs through the
Trk-PI3K-MEK1 signalling pathways to speciﬁc locations in the axon.
The movement of mRNAs appeared to depend on microtubule and
microﬁlament transport (Willis et al., 2007). These ﬁndings set a new
scenario on axonal regeneration. It is now evident that extracellular
stimuli (growth-promoting and inhibitory) can differentially localise
speciﬁc mRNAs in the axons. This could allow the possibility of
manipulating the localisation of mRNAs to promote regeneration such
as in the CNS where many axons are intrinsically incapable of regen-
erating even in a permissive environment.
The modulation of gene expression by the microRNA-mediated
silencing machinery is gaining functional importance in neurons
(Kosik, 2006). Indeed, recent results show that proteins involved in
the processing of miRNAs are localised to developing DRG axons and
growth cones and to mature peripheral axons in vivo. The microRNA
silencingmachinerywas found to be functional in axons andmediated
gene silencing of speciﬁc mRNAs (Hengst et al., 2006; Murashov et al.,
2007). This raised the possibility that axonal microRNAs may be a
feature of mRNA translational regulation and hence, provide alter-
native means for regulating axon regeneration (Hengst et al., 2006).
Interestingly, the microRNA miR132 was shown to be enriched in
neurons and its expression was upregulated by neurotrophins (Vo
et al., 2005). In cortical neurons miR132 expression promoted neurite
outgrowth while its inhibition caused a decrease, providing evidence
that microRNAs are capable of regulating neurite length. Another
study (Aschraﬁ et al., 2008) found that miR338, a brain speciﬁc
microRNA, decreased COXIV mRNA and protein levels with a
concomitant decrease in mitochondrial activity in SCG neurons. The
post-transcriptional regulation of gene expression by miRNAs is
notable. Prospective work will establish whether a correlation can
be made between axonal microRNA content/activity and axon
regeneration ability.
What is lacking at present is an explanation of the apparent
difference between PNS and CNS axons in local translation abilities.
Immunostaining the spinal cord for ribosomal protein P0 shows that it
is only present in the central branches of DRG axons, not in other
CNS axons (Verma and Fawcett; unpublished results). It is possible;
therefore, that many other items of translational machinery andmRNAs have a different distribution in mature CNS axons to the PNS.
Finding out how to regulate the localisation of mRNAs and other
translational molecules in CNS axons will certainly provide ways to
promote and enhance regeneration.
Evidence of local protein synthesis in regenerating axons
The earliest experiments suggesting that local protein synthesis
occurs in regenerating axons go back to the 1960s. At that time, Koenig
found that the level of acetylcholinesterase in cat hypoglossal nerve
increased ﬁve-fold within 24 h after transection (neurotomy), and
that this increase could be greatly reduced by local treatment of a
protein synthesis inhibitor, puromycin (Koenig, 1965, 1967). This
provided the ﬁrst indication that the axons may possess the ability to
synthesise proteins locally. Later on, with his colleagues, he veriﬁed
and further characterised axonal protein synthesis activity using
rabbit hypoglossal nerve transection model. They found that in the
nerve region just proximal to the transection, both the protein content
and protein synthesising activity (as assessed by radiolabelled leucine
incorporation) were elevated after neurotomy (Tobias and Koenig,
1975a). The protein content increases gradually following nerve tran-
section, peaks at 21 h with a doubling of protein content, and returns
to initial level after 96 h. Meanwhile, the protein synthesising activity
reaches a 20-fold increase at about 18 h post-neurotomy, decreases
thereafter but stays at least two-fold higher compared to the initial
level (Tobias and Koenig, 1975a). Interestingly, addition of the protein
synthesis inhibitor cycloheximide, but not chloramphenicol (which
inhibits mitochondrial protein synthesis), abolishes the protein syn-
thesis, indicating that extra-mitochondrial protein synthesis might be
at work (Tobias and Koenig, 1975a). They further showed that this
protein synthesis is localised in the axon by demonstrating that
‘de-centralising’ axons—to disconnect the nerve from the cell body—
has no effect on the protein synthesising activity (Tobias and Koenig,
1975b). Later on, Gaete et al. also obtained a similar result using rat
peroneal nerve injury model (Gaete et al., 1998). Both groups
attempted to demonstrate that the protein synthesis was axonal, by
using axon samples with their myelin sheaths removed (Tobias and
Koenig, 1975a), or by growing axons in an acellular environment
(Gaete et al., 1998). However, the purity of axonal samples obtained
via such methods could not be veriﬁed with certainty.
A similar picture has also been found to be true in in vitro neuronal
cultures. For instance, regenerating goldﬁsh RGCs in culture (grown in
the presence of 5-ﬂuorodeoxyuridine to remove proliferating non-
neuronal cells) actively incorporate tritiated amino acids and [35S]
methionine into axonal proteins, in a process that is inhibited by
cycloheximide (Koenig, 1989; Koenig and Adams, 1982). Regeneration
of a crushed adult mouse sciatic nerve in vitro was also shown to be
partially dependent on local protein synthesis in the injury area
(Edbladh et al., 1994). More recently, using two different preparations
of adult rat DRG neuron cultures, a similar picture was seen. In one,
axons from cultures of conditioned DRG preparations were collected
and incubated in a medium containing [35S]methionine/cysteine.
Radiolabelled proteins were consistently detected in these samples,
indicating that protein synthesis was taking place (Zheng et al., 2001).
In the other, after DRG axons were severed with a glass electrode, the
incorporation of [3H]leucine into axons increased dramatically (Verma
et al., 2005). Furthermore, rapamycin, another protein synthesis inhib-
itor, abolished this activity (see below; Verma et al., 2005).
These, along with our aforementioned observation that axoto-
mised axons—even those isolated from their cell bodies—regenerate a
new growth cone fairly rapidly, provide evidence that local axonal
protein synthesis indeed occurs after injury (Verma et al., 2005).
But what are the proteins synthesised in the axons during re-
generation? While the answer remains ambiguous, cytoskeletal
proteins seem to be the most likely candidates. Frankel and Koenig
discovered a ∼41 kDa protein that was synthesised in transected, but
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actin (Frankel and Koenig, 1978). Besides, analysis of lysates from
regenerating axons of conditioned goldﬁsh RGCs suggests the local
synthesis of actin and tubulin (Koenig, 1989). Studies on regenerating
PC12 cells and conditioned DRGs, meanwhile, showed that the trans-
lation of ribosomal protein L4 mRNA is required for efﬁcient axon
regeneration, as knocking down the mRNAs with antisense oligonu-
cleotides resulted in failure of regeneration (Twiss et al., 2000).
The axonal synthesis of another protein, importin β1—which
belongs to the karyopherin family that regulates the translocation of
nuclear localisation signal (NLS)-bearing proteins into the nucleus—
has also been found to be upregulated following a nerve lesion (Hanz
et al., 2003). Likewise, an intermediate ﬁlament, vimentin, is also
actively synthesised after a nerve injury (Perlson et al., 2005; Willis
et al., 2005). This newly–synthesised vimentin ﬁrst undergoes pro-
teolysis, and the proteolytic fragments in turn link up with importin
β1, and together they are retrogradely transported to the cell body
(Perlson et al., 2005). While being transported, they help to ferry a
cargo, now identiﬁed as phosphorylated ERK 1/2 (pErk), which may
have a signalling function in the cell body (Perlson et al., 2005;
Reynolds et al., 2001; Sung et al., 2001). It is therefore noteworthy that
rapid phosphorylation of ERK 1/2 takes place after an injury (Chierzi
et al., 2005; see below). (For a more detailed account on this theme,
see review by Rishal and Fainzilber, 2010.)
Recently, Willis et al. attempted to catalogue the axonally-
synthesised proteins in DRG neurons cultured from adult rats that
had been injury-conditioned by a sciatic nerve crush (also see review
by Yoo et al., 2010). By employing a proteomics approach to analyse
axonal lysates from the injury-conditioned animals, more than 100
proteins were identiﬁed (Willis et al., 2005). As expected, a number of
cytoskeletal proteins were among them, including β-actin, peripherin,
vimentin, γ-tropomyosin 3 and coﬁlin-1 (Willis et al., 2005).
Surprisingly, many non-structural proteins were also found to be
synthesised in the axons. These include heat shock proteins, resident
ER proteins, anti-oxidant proteins andmetabolic proteins (Willis et al.,
2005). Working on cultures of condition-injured DRG neurons of Xe-
nopus laevis, Tonge et al. metabolically labelled the axons in a
compartmentalised chamber, and subsequently collected the cell
bodies for analysis (Tonge et al., 2008). Usingmass spectrometry, they
identiﬁed 35 proteins that were synthesised in the axons and
transported retrogradely back to the cell bodies, including cyto-
skeletal/cytoskeletal-binding proteins, calcium ion-binding proteins,
annexins, translation factors, and the ubiquitin–proteasome system
(Tonge et al., 2008). The pool of newly synthesised cytoskeletal
proteins is likely to act as a source of structural proteins for growth
cone re-formation and axon growth (Willis and Twiss, 2006; Zhang
et al., 2001), as well as to regulate cytoskeletal dynamics (Bamburg
et al., 1999; Ghosh et al., 2004). Further studies are necessary to
discover the roles, if any, of these proteins in the context of nerve
injury and axon regeneration.
Attempts were also made to understand the mechanism that
mediates the local protein synthesis (Fig. 1C). In view of the involve-
ment of mammalian target of rapamycin (mTOR) and the mitogen-
activated protein kinase p38 in regulating local protein synthesis in
axon guidance, Verma et al. (2005) investigated if a similar mecha-
nism is employed in axon regeneration. In cultures of DRG neurons
and RGCs, addition of the inhibitors to these molecules signiﬁcantly
diminishes both the incorporation of [3H]leucine into axonal proteins,
and the regeneration of new growth cones after axotomy (Verma
et al., 2005). Recently, He and co-workers created mice inwhich PTEN
(phosphatase and tensin homolog), a negative regulator of mTOR
pathway, was removed from the RGCs via a conditional knockout
approach. They found that, when compared to wild-type mice, these
animals exhibited better regeneration of RGC axons after an optic
nerve injury (Park et al., 2008). Although in this case, the effect of
the elimination of PTEN on mRNA translation is a global one, thelocalised protein synthesis within the axon would also be affected,
thus not necessarily negating a role for local protein synthesis in
axon regeneration.
Other signalling molecules such as extracellular signal-regulated
kinase 1,2 (ERK 1/2) and protein kinase A (PKA) were also found to be
important in ensuring successful growth cone regeneration of DRG
neurons axotomised in vitro (Chierzi et al., 2005). Although the
association with protein synthesis is not immediately clear, it was
speculated that they may be involved in the synthesis of growth-
related proteins from axonally-localised mRNAs, not unlike the role of
ERK in regulating growth cone chemotropic responses to diffusible
cues (Campbell and Holt, 2003; Chierzi et al., 2005). Alternatively,
activated forms of signalling molecules (e.g. pErk) can be retrogradely
transported to the cell body, and may act as an ‘injury signal’,
informing the cell body of the injury occurring distally (Perlson et al.,
2005; Reynolds et al., 2001; Sung et al., 2001). Besides, calcium also
appears to be crucial for successful axon regeneration (Chierzi et al.,
2005; Yudin et al., 2008; see below). It was shown that calcium is
required to regulate the binding of the components of the importin
retrograde signalling complex; and may also be involved in the
translation of these components such as importin β1 and vimentin
(Perlson et al., 2006; Yudin et al., 2008).
To determine if there is any relationship between the regenera-
tive capacity of different neurons of varying ages and local protein
synthesis, the levels of various protein synthesis machineries within
the axons had been compared. By performing quantitative immuno-
ﬂuorescence (QIF) assays on cultured DRG neurons and RGCs, it
was found that the levels of ribosomal protein P0 and phosphorylated
initiation factor eIF-4E in the axons decrease with developmental
age. Moreover, the levels in the CNS (i.e. RGCs) are much lower
compared to those in the PNS (i.e. DRG neurons) (Verma et al., 2005).
This could well explain the progressive loss of regenerative potential
as neurons age as well as the limited ability of CNS neurons to
regenerate as compared to PNS neurons. Indeed, in adult mouse RGCs,
it was observed that the mTOR activity and new protein synthesis
was impaired after an axotomy, which may result in the failure of
regeneration. Nevertheless, in mice in which tuberous sclerosis
complex 1 (another negative regulator of the mTOR pathway) was
conditionally knocked out, robust regeneration ensued (Park et al.,
2008). This suggests that promoting protein synthesis could be an
effective approach to enhance regenerative capacity, even in neurons
that normally lack such ability.
The role of protein degradation in regenerating axons
Axotomised regenerating axons undergo rapid dramatic anatomi-
cal changes in vitro and in vivo. As previously mentioned, soon after
transection, the axons retract, re-form a growth cone and elongate
forward. These morphological and functional changes are accompa-
nied by a rapid turnover of proteins involving a dynamic balance
between local synthesis of new proteins and degradation of pre-
existing ones. In the past decade, local protein synthesis in the axon
has increasingly gained attention; however, the role of protein de-
gradation in axon regeneration has been given less consideration.
Role of the ubiquitin–proteasome system in axon regeneration
The degradation of proteins in the axon can take place by differ-
ent proteolytic pathways that include the ubiquitin–proteasome
system (UPS), calcium-mediated proteolysis and autophagy-mediated
degradation. Of these proteolytic systems, the UPS has been described
as a major player in regulating a multitude of cell processes and
dynamics; increasing evidence has also shown that its impairment
may lead to neuronal dysfunction (extensively reviewed by Glickman
and Ciechanover, 2002; Johnston and Madura, 2004; Murphey and
Godenschwege, 2002; van Tijn et al., 2008).
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one is ubiquitin, a 76 amino acid polypeptide. Through a series of
complex multi-step reactions, ubiquitin is activated by the E1
ubiquitin-activating enzyme and transferred to the ubiquitin carrier,
the E2 ubiquitin conjugating enzyme. The E3 ubiquitin ligase enzymes
will recognise proteins to be targeted for degradation by the pro-
teasome and will either transfer the ubiquitin directly to a lysine
residue at position 48 on the protein substrate or transfer ubiquitin
from the E2 enzyme to the E3 ligase and then to the substrate. Protein
substrates tagged with multi-ubiquitin chains are then selectively
degraded by the 26S proteasome into small peptides. The 26S pro-
teasome is a multi-subunit protease complex, composed of a 20S core
particle and by at least one 19S regulatory particle. Once the target
protein has been proteolytically degraded, the ubiquitin hydrolase-
catalysed depolymerisation of the polyubiquitin chain will release
recyclable monomeric ubiquitins. The protein substrates of the UPS
are generally short-lived cytoplasmic and plasma membrane, mis-
folded or damaged proteins which must be structurally different from
stable and essential proteins.
In the 1980s a number of studies reported axonal transport and
localisation of tRNA in vertebrate axons. Interestingly, the amount of
transported tRNA appeared to increase during development and
regeneration (Chakraborty and Ingoglia, 1993). Although initially it
was thought that tRNA contributed only to protein synthesis, later it
was established that tRNA also worked as an amino acid donor that
posttranslationally argynilates proteins at the N-terminus for ubiqui-
tin-mediated proteolytic degradation (Chakraborty and Ingoglia,
1993; Ferber and Ciechanover, 1987; Jack et al., 1992). In regenerating
sciatic nerves, an increase in N-terminal argynilated and ubiquitinated
proteins was observed (Jack et al., 1992). Conversely, in the optic nerve
(poor regenerative ability), N-argynilation did not occur until several
days after the injury (Shyne-Athwal et al., 1988; Shyne-Athwal et al.,
1986; Zanakis et al., 1984). Thereby, it was hypothesised that the UPS
might be important for nerve regeneration suggesting that UPS-
mediated protein degradation occurs in regenerating axons but fails to
occur in non-regenerating ones.
The elucidation of the localisation and function of theUPSmachinery
in the growth cones came from Campbell and Holt (2001) (Fig. 1A). In
this work several components of the proteasome and its related
signalling molecules (for example, 20S proteasome “core”, csn8 protein
of the COP9 signalling complex (regulator of UPS) and ubiquitin) were
detected by immunohistochemistry in developing RGC growth cones
of Xenopus laevis in culture. Further studies showed that components
of the UPS were present in mammalian axons, these included the
ubiquitin–conjugating enzyme HR6B (Kavakebi et al., 2005), 20S
proteasome “core”, ubiquitin and ubiquitinated protein (Verma et al.,
2005), the Ring-ubiquitin-ligase Rnf6 (Tursun et al., 2005) and the
E3-ubiquitin ligase (Lewcock et al., 2007). Apart from its presence in the
axons and growth cones the UPS components were also functional. For
example, treatmentof isolatedgrowthconeswithproteasome inhibitors
prevented chemotropic-mediated growth cone turning (Campbell and
Holt, 2001). In cultured mammalian sensory and superior cervical gan-
glion (SCG) neurons, treatment with a variety of proteasome inhibitors
(namely lactacystin, and the dipeptide Leu-Ala) reduced or inhibited
axonal outgrowth of newly plated neuronswhile in established cultures
they induced a dose-dependent decrease in axonal length (Kavakebi
et al., 2005; Klimaschewski et al., 2006; Laser et al., 2003). Additionally,
it was observed that proteasomal inhibition induced the fragmenta-
tion and dispersion of high molecular weight neuroﬁlaments in the
growth cones and axons of a subpopulation of neurons (Klimaschewski
et al., 2006).
It was not until recently that the role of UPS-mediated degradation
was assessed in growth cone formation after axotomy (Verma et al.,
2005). Indeed it was shown that proteasomal inhibitors decreased the
regeneration of isolated growth cones in cultured rat sensory axons
throughout all developmental stages (embryonic, neonate and adult)and to a much lesser extent in adult retinal axons, which already
presented limited regeneration. In vivo it was shown that a lesion
could increase the levels of protein degradation machinery proximal
to the site of injury. Thus, the UPS appeared to be necessary for growth
cone regeneration (Verma et al., 2005).
Very fewmechanisms have been proposed to explain how the UPS
mediates axon regeneration. Nevertheless, it is widely accepted that
ubiquitination events are required for correct neuronal function
(Murphey and Godenschwege, 2002; van Horck et al., 2004).
Attempts to explore the links between components of the UPS, sig-
nalling pathways and axonal growth cone dynamics suggest that
degradation of cytoskeletal components could be a limiting step in
regulating axonal regeneration (Lewcock et al., 2007; Tursun et al.,
2005). For example, the expression levels of the Ring-ubiquitin-ligase
Rnf6 indirectly modulate neurite length by targeting LIMK1 (a
regulator of the cellular actin cytoskeleton) for proteasomal degrada-
tion by polyubiquitination (Tursun et al., 2005). A similar picture has
also been found with the E3-ubiquitin ligase Phr1. Phr1 is associated
with stable microtubules in the axon shaft of sensory and motor
neurons. Interestingly, Phr1 regulates the levels of the DLK protein by
targeting it for proteasomal degradation with consequences for the
stability of microtubules and hence growth cone and axon morphol-
ogy (Lewcock et al., 2007).
Although several reports have established links between the UPS
and the growth cone/axon dynamics, several other questions remain
open and require further exploration. For example, it appears that the
conjugation of ubiquitin to a substrate is a very speciﬁc reaction that
derives from speciﬁc combinations of ubiquitin conjugating (E2) and
ubiquitin ligase (E3) enzymes (Watts et al., 2003) however, it is
unknown how axotomy or axonal injury triggers the ubiquitination of
speciﬁc proteins. Also, it is unknown how UPS-mediated protein
degradation in the axon or growth cone is spatially regulated and
the timeframe overwhich occurs after injury. For example, the vicinity
of the ubiquitin ligases to the substrate or the spatial restriction of
the different components of the proteasome into subcellular compart-
ments might regulate the degradation process. Furthermore, the
temporal speciﬁcity of ubiquitination will depend on the stability/
instability of proteins, the posttranslational modiﬁcations such as
phosphorylation and on the susceptibility of ligases to second
messengers such as Ca2+ (see review by Hedge, 2004). For example,
a transient intracellular inﬂux of Ca2+ after axotomy might regulate
the ubiquitination of speciﬁc proteins, in particular since a similar
modulation of ubiquitination by Ca2+ has been described for mole-
cules related to synaptic plasticity (Abrams et al., 1998; Onyike et al.,
1998; Speese et al., 2003; Zhao et al., 2003). Recently, Staal et al.
investigated the role of the UPS in mammalian CNS axons after a
stretch injury (Staal et al., 2009). It was observed that after injury
the accumulation of ubiquitin in these axons was temporally and
spatially associated with cytoskeletal rearrangements suggesting that
UPS activity might help to reorganise the cytoskeleton in CNS axons
after injury.
In summary, components of the UPS are present in regenerating
and non-regenerating axons. In regenerating axons it appears that
UPS activity and its inhibition correlate with growth cone regenera-
tion success and with axonal protection after injury (Verma et al.,
2005; Staal et al., 2009). However, further work will need to highlight
how speciﬁc substrate ubiquitination occurs after axotomy and how
these events are spatially and temporally controlled since untimely
and excessive degradation could become detrimental for the regen-
eration of the axon.
Calcium/calpain-mediated proteolysis in growth cone re-formation
Apart from the proteasome-dependent protein degradation, ex-
tensive studies in Aplysia have shown that calcium/calpain-mediated
proteolysis also has a major role in growth cone re-formation and
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involvement of calcium ions in the formation of growth cones has
been supported by several experiments. Firstly, after an axotomy,
intracellular calcium concentration, [Ca2+]i, rises rapidly at the site of
transection, with the level reaching more than 1 mM (Fig. 1B). This
increase in [Ca2+]i can be attributed to the sudden inﬂux of calcium
ions into the axoplasm through the ruptured membrane (Ziv and
Spira, 1995; Ziv and Spira, 1997), the opening of voltage-gated calcium
channels, or the inversion of Na+/Ca2+ exchanger (Mandolesi et al.,
2004). Secondly, the newly-formed growth cone always arises from
the area where [Ca2+]i is elevated (Ziv and Spira, 1997). Thirdly, a
transient elevation of [Ca2+]i to 300–500 μM in intact axons by
microinjection of calcium ionophore leads to the formation of a new
growth cone and neurite (Ziv and Spira,1997). Fourthly, using electron
microscopy, the region experiencing a [Ca2+]i elevation has been
observed to be also undergoing ultrastructural alterations and
reorganisation of cytoskeletal structures, including microtubules and
neuroﬁlaments (Benbassat and Spira, 1993; Ziv and Spira, 1997).
Nevertheless, it must be noted that the increase in [Ca2+]i has to be a
transient event. The ultrastructural change at the cut tip only occurs
after the [Ca2+]i has returned to its original level; and a new growth
cone only begins to spread after the recovery of [Ca2+]i (Benbassat
and Spira, 1993; Ziv and Spira, 1997). After all, Aplysia axons com-
pletely re-seal after axotomy within 5 min, thus it makes sense that
intracellular calcium buffers would be able to regulate the [Ca2+]i
thereafter (Gabso et al., 1997; Spira et al., 1993, 1996). The transient
elevation of [Ca2+]i then causes the activation of calcium-dependent
proteases, which in turn carry out the process of protein degradation
necessary for successful regeneration. Following the transection of
an axon, intra-axonal proteolytic activity increases transiently, in a
spatial and temporal distribution that closely resembles that of the
transient [Ca2+]i increase post-axotomy (Gitler and Spira, 1998). A
similar rise in [Ca2+]i is also thought to occur in mammalian axons. In
cultured CNS neurons, axotomy leads to an [Ca2+]i increase, which is
thought to be the result of the opening of voltage-gated calcium
channels by action potentials (Mandolesi et al., 2004). In addition,
axotomy of DRG axons in a calcium-free medium greatly impairs
growth cone regeneration (Chierzi et al., 2005).
Both the rise in proteolytic activity and the formation of the
growth cone after axotomy can be inhibited by the application of
calpeptin, an inhibitor of the calcium-dependent protease calpain,
suggesting that calpain could be the mediator of the proteolysis
(Gitler and Spira, 1998). In animal models of spinal cord injury, the
level of calpain in spinal cord extracts from injured rats increases
signiﬁcantly within 1 h, compared to those from uninjured rats (Banik
et al., 1997; Springer et al., 1997).
Several mechanisms have been proposed to explain the actual
function of calcium/calpain-mediated proteolysis in axon regenera-
tion after injury. One suggestion is that calpain helps in the initial re-
sealing of the damaged plasma membrane after transection, as
exhibited in invertebrate (Godell et al., 1997) and vertebrate models
(Howard et al., 1999; Shi et al., 2000; Yoo et al., 2003). Other evidence
points to the proteolysis of a submembrane cytoskeletal component,
spectrin, that links the plasmamembrane to intracellular cytoskeleton
(Bennett and Baines, 2001). It has been suggested that the removal of
spectrin facilitates the fusion of intracellular granules to the inner
surface of the membrane during exocytosis (Aunis and Bader, 1988).
Therefore, after axotomy, the upregulation of calpain-mediated break-
down of spectrin may lead to better fusion of axoplasmic vesicles to
the membrane, helping the construction of a growth cone or exten-
sion of the axon (Gitler and Spira, 1998). Also, as mentioned above,
axotomy of an Aplysia axon brings about a reorganisation of the
cytoskeleton, involving an initial disassembly and breakdown of
microtubules and neuroﬁlaments, followed by the division of the cut
axon tip into three zones (Sahly et al., 2006). If the axotomy is per-
formed in the presence of calpeptin, these events fail to take place;but if calpeptin is added 4–5 min after axotomy, a growth cone with
an expanding lamellipodium occurs, but at a much slower rate (Sahly
et al., 2006). Besides, as alluded to before, sciatic nerve injury in rats
triggers the synthesis of new vimentin that assists in the retrograde
transport of signalling molecules such as pErk (see above). However,
these newly synthesised vimentin molecules need to be broken down
ﬁrst by calpain-mediated proteolysis, and the resulting vimentin
fragments are then able to transport pErk, along with importin β1
(Perlson et al., 2005; reviewed by Willis and Twiss, 2006).
In vivo experiments using rat spinal cord injury models have
demonstrated that neuroﬁlament, spectrin and microtubule-
associated protein 2 (MAP2, albeit in the somatodendritic region)
within the spinal cord undergo proteolysis induced by calpain (Banik
et al., 1997; Springer et al., 1997). However, these studies appear to
suggest that the proteolytic activity results in neuronal dysfunction,
neuronal loss, tissue necrosis and even axon degeneration (Banik
et al., 1997; Springer et al., 1997). Nevertheless, these seemingly
contradicting results may be explained by the time-course of the
proteolytic events studied, as well as the sample used. Firstly, ex-
periments on cultured neurons looked at the rise of [Ca2+]i within
minutes, and a new growth cone normally re-forms within tens
of minutes; whereas the increase in calpain activity in the in vivo
studies occurred over 1 to 72 h (Banik et al., 1997; Spira et al., 2001;
Springer et al., 1997). Indeed, the intra-axonal ultrastructural altera-
tions that precede the formation of growth cone only takes place
after the transient increase in [Ca2+]i has ended (within minutes) and
the [Ca2+]i has returned to control level (Benbassat and Spira, 1993;
Ziv and Spira, 1997). Secondly, the enhanced calpain activity in the
whole spinal cord may have come from non-neuronal sources such
as reactive glial cells and inﬂammatory cells, and not just limited to
the tiny vicinity near the cut axon tip (Banik et al., 1997). It is possi-
ble that there are differences between mammalian and invertebrate
axons. In a recent study of developing mouse hippocampal neurons
application of the calpain inhibitor calpeptin to the axons of cul-
tured hippocampal neurons induced neurite sprouting and a new
growth cone (Mingorance-Le Meur and O'Connor, 2008). This discre-
pancy from the results from the Spira laboratory could reﬂect the
use of different cell types, developmental stages or species. More
work on mammalian models would provide more insights into
understanding the actual role of calpain in growth cone formation.
At present, most of the information about calcium changes in cut
axons comes from in vitro experiments. Exactly what happens in
mammalian PNS and CNS axons may differ somewhat from this
picture, and there could be differences between central and periph-
eral axons.
Possible role of autophagy in axon regeneration
Autophagy (self-eating) is the name used for any intracellular
process that results in the degradation of cytoplasmic components
inside lysosomes (Cuervo, 2004). It is thought to contribute toward
cellular homeostasis by degrading long-lived stable proteins and
appears to be the only mechanism by which entire organelles such
as mitochondria, peroxisomes and regions of Golgi and ER are
degraded. In addition, autophagy has also been implicated in cellular
differentiation, growth control, cell death and neurodegenerative
diseases (reviewed by Cuervo, 2004; Larsen and Sulzer, 2002;
Rubinsztein et al., 2005). Components of the autophagic machinery
have been detected in living neurons in culture and in vivo (Cubells et
al., 1994; Hollenbeck, 1993; Rubinsztein et al., 2005). There are studies
that suggest that axotomised neurons exhibit features resembling
autophagic activity in the cell body and in the axon initial segment,
including chromatolysis and the appearance of autophagosomes
(Matthews, 1973; Matthews and Raisman, 1972; Rubinsztein et al.,
2005). More recently, autophagy has been shown to be required for
axonal homeostasis and prevention of degeneration in mouse
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another report found that autophagy was induced in degenerating
SCG neurites after nerve growth factor (NGF) withdrawal (Yang et al.,
2007). These results suggest that autophagy might contribute toward
the homeostasis and maintenance of the axons; future work is needed
to elucidate its role in axons from other neuronal types and whether
its activity might be linked to regeneration. The role of autophagy
in axon regeneration remains speculative, as no direct evidence exists
to associate autophagy-mediated degradation of proteins with the
onset of the axonal regeneration programme.
Conclusion
The ﬁrst step to ensure successful regeneration after an axon is cut
is the formation of a growth cone. However, a sequence of several
other events must take place before the growth cone is formed. The
axon will retract, pause, regenerate a growth cone and then elongate
forward. This series of events can take place within one day in vivo
(Friede and Bischhausen, 1980; Pan et al., 2003) and as quickly as a
few hours in vitro (Chierzi et al., 2005; Verma et al., 2005). They also
occur too rapidly for a cell body to receive retrograde signals formed
at the injured site and to respond accordingly by sending the required
proteins through axonal transport. The same holds true for compo-
nents of the numerous proteolytic machineries that must be already
in place to help degrade and depolymerise proteins during the re-
traction and subsequent phases (Campbell and Holt, 2001; Verma
et al., 2005). Thus, the regeneration of an axon that culminates in the
formation of a growth cone involves a complex and dynamic
succession of molecular and anatomical events. An increasing number
of reports are elucidating how local protein synthesis and degradation
occur separately in the axon and growth cone in response to speciﬁc
cues. However, it still remains unknown how the cellular machinery
at the axon tip integrates and coordinates these processes in order to
accomplish and maintain the appropriate levels of thousands of pro-
teins necessary for regeneration. The future challenge is to understand
how this complex network of processes interacts and cross-talks in
order to promote regeneration after injury.References
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